InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SFY | Ann: Daily Fund Update | 06/09/19 | 0 | 1 | |||
|
|||||||
SFY | Ann: Distribution Announcement March 2019 | 28/03/19 | 0 | 35 | |||
|
|||||||
SFY | Ann: Daily Fund Update | 27/03/19 | 0 | 53 | |||
|
|||||||
SFY | Ann: Daily Fund Update | 26/03/19 | 0 | 58 | |||
|
|||||||
SFY | Ann: Daily Fund Update | 25/03/19 | 0 | 56 | |||
|
|||||||
SFY | Ann: Daily Fund Update | 25/03/19 | 0 | 75 | |||
|
|||||||
SFY | Ann: SFY Estimated Distribution Announcement | 22/03/19 | 0 | 61 | |||
|
|||||||
SFY | Ann: Daily Fund Update | 21/03/19 | 0 | 64 | |||
|
See All Discussions